Friedrich W J Helling

Friedrich W J Helling has extensive experience in the pharmaceutical industry, with a focus on process development, manufacturing sciences, and technology. Friedrich W J currently holds the position of Vice President, Process Development & Manufacturing Sciences at Dynavax Technologies, where they are responsible for strategy and execution of development plans and improvements for pipeline and existing products. Prior to that, they served as the Head of Manufacturing Science and Technology at Dynavax, leading a team that implemented new technology and achieved significant yield improvements.

Before joining Dynavax, Friedrich held several key positions at GSK and Novartis Vaccines & Diagnostics. At GSK, they spearheaded the integration of the Novartis MSAT organization into the GSK Vaccines organization, establishing local MSAT across all manufacturing sites and providing technical support and troubleshooting. At Novartis, they served as the Global Head of Manufacturing, Science, and Technology, overseeing global manufacturing sites, managing compliance, and introducing process changes. Friedrich W J also led the development and implementation of Quality by Design concepts, leading to increased robustness and capability in manufacturing operations.

Friedrich's early career includes a role as a Plant and Project Manager at Chiron Vaccines. Overall, they have demonstrated a strong track record of leadership and technical expertise in driving process improvements and technological advancements in the pharmaceutical industry.

Friedrich W J Helling completed a Doctor of Philosophy (Ph.D.) in Biochemistry at The Philipp University of Marburg.